VistaGen Therapeutics, Inc. ( VTGN) - Key Metrics
VTGN Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2027Q1 | $0.03 | -$0.30 | -$0.34 | -$0.34 |
| 2026Q4 | $0.01 | -$0.43 | -$0.43 | -$0.43 |
| 2026Q3 | $0.01 | -$0.45 | -$0.42 | -$0.42 |
| 2026Q2 | $0.01 | -$0.54 | -$0.38 | -$0.39 |
| 2026Q1 | $0.01 | -$0.47 | -$0.59 | -$0.59 |
VTGN Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2027Q1 | 0% | -0.19 |
| 2026Q4 | 0% | -0.35 |
| 2026Q3 | 0% | -0.37 |
| 2026Q2 | 0% | -1.64 |
| 2026Q1 | 0% | -1.06 |
VTGN
Price: $0.20
52 week price:
Payout Ratio Range:
Earnings Per Share: -1.66 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 11.3 million
Ebitda: -2.8 millionMarket Capitalization: 12.5 million